(Q34254020)

31 July 2017

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis (English)

1 reference

31 July 2017

0 references

1 reference

11

1 reference

31 July 2017

Renske D. Steenbergen

0 references

author name string

S M Wilting

1

1 reference

31 July 2017

P J F Snijders

2

1 reference

31 July 2017

W Verlaat

3

1 reference

31 July 2017

A Jaspers

4

1 reference

31 July 2017

M A van de Wiel

5

1 reference

31 July 2017

W N van Wieringen

6

1 reference

31 July 2017

G A Meijer

7

1 reference

31 July 2017

G G Kenter

8

1 reference

31 July 2017

Y Yi

9

1 reference

31 July 2017

C le Sage

10

1 reference

31 July 2017

C J L M Meijer

12

1 reference

31 July 2017

R D M Steenbergen

13

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 February 2012

1 reference

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

1

1 reference

31 July 2017

106-116

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.20

31 July 2017

0 references

cites work

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

A microRNA expression signature for cervical cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Altered MicroRNA expression in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Patterns of known and novel small RNAs in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

MicroRNA expression variability in human cervical tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

microRNAs exhibit high frequency genomic alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Nonparametric testing for DNA copy number induced differential mRNA gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Evolution of microRNA expression during human bronchial squamous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Methylation of human microRNA genes in normal and neoplastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Biomarkers in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Generation of patterns from gene expression data by assigning confidence to differentially expressed genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Development and duration of human papillomavirus lesions, after initial infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Aberrant microRNA expression in human cervical carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Coupled analysis of gene expression and chromosomal location

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

inferred from DOI database lookup

7 January 2021

based on heuristic

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.20

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference